Amgen’s first quarter results reflected robust demand across its portfolio, with product volumes and sales increasing in both ...

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...

Shares of Amgen Inc. AMGN rallied 1.03% to $280.35 Wednesday, on what proved to be an all-around mixed trading session for ...

In the most recent trading session, Amgen (AMGN) closed at $280.35, indicating a +1.03% shift from the previous trading day.

Drugs such as Ozempic (a brand name for semaglutide) are showing promise for weight loss. Another medication in the same ...

A new drug from California-based pharma company Amgen, which has concluded a phase II trial, shows promise as a powerful ...

Alternatives to weekly injections of weight-loss drugs may be on the way. A monthly dose of a new drug called MariTide helped ...

Corporates don't want Copilot Software King of the World, Microsoft is finding out the hard way that even a decades-long grip ...

The once-monthly drug is still under study but could provide added convenience and another option for patients.

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Accord Healthcare’s Henlius-partnered Hetronifly ...

Keurig Dr Pepper Inc. (NASDAQ:KDP) is one of the 12 stocks on Jim Cramer’s radar recently. A caller asked if the company ...

According to the report, pharmaceutical company Amgen has paid for a 20,000 user plan for Microsoft Copilot, but more than a year later its employees still prefer to work using ChatGPT.